Safety of protease inhibitors and Arbidol for SARS-CoV-2 pneumonia in Zhejiang Province, China

The aim of this study was to evaluate the safety of an antiviral regimen of protease inhibitors combined with Arbidol (umifenovir) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia patients. The genomic sequence of SARS-CoV-2 is highly homologous to that of SARS-CoV (Zhou et...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yong-zheng, Xu, Kai-jin, Li, Yong-tao, Fu, Jia-dan, Xu, Min, Yu, Ling, Sheng, Ji-fang, Zhu, Biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Zhejiang University Press 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759455/
https://www.ncbi.nlm.nih.gov/pubmed/33843160
http://dx.doi.org/10.1631/jzus.B2000204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759455/
https://www.ncbi.nlm.nih.gov/pubmed/33843160
http://dx.doi.org/10.1631/jzus.B2000204

Ejemplares similares